Clinical Trials
38 trialsApixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
Academic and Community Cancer Research United
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Mayo Clinic
ONCO PE
Kyoto University, Graduate School of Medicine
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
Sixth Affiliated Hospital, Sun Yat-sen University
COSIMO
Bayer
ONCO DVT
Kyoto University, Graduate School of Medicine
CANVAS
Alliance Foundation Trials, LLC.
VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program
Nordsjaellands Hospital
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
ONCOTHROMB
Hospital General Universitario Gregorio Marañon
D-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs
G. d'Annunzio University
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Short-term Perioperative Thromboprophylaxis After Major Abdominal Surgery
Istanbul Medeniyet University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
PREDICARE
LEO Pharma
Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer
G. d'Annunzio University
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
DISOLVE
University of Vermont
CAP
University Hospital, Akershus
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
REMARK
Ottawa Hospital Research Institute
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
GlaxoSmithKline
MICA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
High-dose Periop Statins for Prevention of DVT
Yale University
SOME
Ottawa Hospital Research Institute
Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection
McMaster University
PERI-OP
Ottawa Hospital Research Institute
Study on Thrombosis Therapy in German Cancer Patients
LEO Pharma
GIVTE
University of Aarhus
3 Screen Electronic Alert
Brigham and Women's Hospital
Ultrasound (US)-Doppler for the Diagnosis of Asymptomatic Deep Vein Thrombosis (DVT) in Gynecologic Cancer Patients
Rambam Health Care Campus
US-Doppler and Procoagulant Microparticles for the Diagnosis of Asymptomatic DVT in Advanced Cancer Patients With Poor Performance Status
Rambam Health Care Campus
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
Rovi Pharmaceuticals Laboratories
Epidemiology of Venous Thromboembolism
Brigham and Women's Hospital
Multi-Center Human Alert Trial to Prevent DVT and PE
Brigham and Women's Hospital
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)